资讯

FDA announces change to future Covid-19 vaccine approvals that will limit fall boosters
The agency is changing the standard of evidence required for Covid-19 vaccine approval in the US, Dr. Vinay Prasad, the new ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
Healio30 分钟
FDA will restrict future COVID-19 vaccines based on age, risk factors
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
PharmExec2 小时
FDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
New Trump vaccine policy limits access to COVID shots
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
Tampa Free Press on MSN1 小时
FDA Overhauls COVID-19 Vaccine Approval Process, Shifting Focus To High-Risk Individuals
The U.S. Food and Drug Administration (FDA) is set to significantly alter its approach to approving COVID-19 vaccines, a move that will primarily limit future vaccine recommendations to older ...
New FDA requirements for COVID-19 vaccines in healthy adults, children
COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift ...
Becker's Hospital Review1 小时
FDA narrows COVID-19 vaccine access to older adults, high-risk groups
The FDA announced it will limit full approval of future COVID-19 booster vaccines to individuals older than 65 and those at high risk for severe disease, marking a shift from the agency’s previous one ...